3 news items
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
OCUL
16 Apr 24
of increasing responsibility at Regeneron Pharmaceuticals, Inc., Genentech, Inc., Merck & Co., as well as Oyster Point Pharma, Inc., Ocular
Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO
OCUL
15 Apr 24
and CEO, effective immediately. In addition to his new responsibilities, Dr. Dugel will continue to serve as a director and as Executive Chairman
Decoding 6 Analyst Evaluations For Ocular Therapeutix
OCUL
13 Mar 24
, it signifies their response to recent developments related to Ocular Therapeutix. This offers insight into analysts' perspectives on the current state
- Prev
- 1
- Next